IndraLab

Statements



reach
"71 N-palmitoylethanolamine, a cannabinoid receptor CB2 agonist, has been compounded into creams and shown to reduce pruritus within days in patients with AD, lichen simplex chronicus, prurigo nodularis, and uremic pruritus."